OtherJournal of intellectual disability research : JIDR2025

Off-Label Antipsychotic Withdrawal in People With Intellectual Disabilities: Development and Internal Validation of a Prediction Model.

Joëlle Weijgertze-Lanser, Maureen B G Wissing, Roy G Elbers and 3 others

PMID 40908653

WHAT IT FOUND

Severe/profound intellectual disability, higher baseline defined daily dose and higher stereotypy scores predicted unsuccessful off-label antipsychotic withdrawal.

The model was tested only on the same data and did not explain all outcomes.

Key findings

01Seventy of 141 participants did not successfully withdraw by the end of the intervention period.

02Severe/profound intellectual disability, higher baseline DDD and higher ABC stereotypy scores predicted unsuccessful off-label antipsychotic withdrawal.

03The prediction model explained 20% of the variance in withdrawal outcome.

STILL TO COME

How it was doneWhat they found

Read the rest of this summary

You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.

Already have one?

What it does not show

The model was developed and internally validated on the same combined data, so it has not been tested in a new sample. The combined sample was relatively small, so only seven baseline variables could be included, and potentially relevant factors such as sex, previous withdrawal attempts, caregiver attitude, parkinsonism and akathisia were not in the final model. The two source studies differed in design and withdrawal outcome, with Study 1 having a higher unsuccessful withdrawal rate than Study 2. Some movement disorder variables could not be combined because Study 1 and Study 2 measured dyskinesia, parkinsonism and akathisia differently. There was a 10-year gap between the studies, so variables important in later literature were not available in Study 1. The outcome was dichotomous: withdrawal was counted unsuccessful if it was stopped before reaching zero, so partial reductions that may still be clinically useful were not captured. The model explained only 20% of the variance, so the included predictors did not account for most of the withdrawal outcome.

The easy way to misread this

Do not use this model as a ready clinical decision rule. It was developed and tested only on the same combined data, not in a new sample, and it did not explain all withdrawal outcomes.

Summarised by AI from the full paper, without a clinician reviewing it. Check it against the source before it changes what you do. Read it on PubMed →


The study

Participants
141 participants analysed (Study 1, n = 98; Study 2 withdrawal group, n = 43)
Certainty of evidence
Low

Browse

    Cite

    Joëlle Weijgertze-Lanser, Maureen B G Wissing, Roy G Elbers, et al. Off-Label Antipsychotic Withdrawal in People With Intellectual Disabilities: Development and Internal Validation of a Prediction Model. Journal of intellectual disability research : JIDR. 2025.

    Read the original — we summarise, we never replace the paper.